The Christie Charity
The list below shows The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.
If you would like to know how to access our trials, please see how to contact us.
- RESMAIN - Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.
Suitable for patients who have received treatment and their lymphoma is stable or in remission.
- PROCLIPI - A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.
- SGN35-032 - A phase 2 trial of brentuximab vedotin plus chemotherapy in people with peripheral T-cell lymphoma.
- PRIMO - A phase 2 trial of duvelisib in people with relapsed or refractory peripheral T cell lymphoma.
With special thanks to the following:
